OBJECTIVE: Because the decision to hospitalize an infant with bronchiolitis is often supported by subjective criteria and objective indicators of bronchiolitis severity are lacking, we tested the hypothesis that lactate dehydrogenase (LDH), which is released from injured cells, is a useful biochemical indicator of bronchiolitis severity. PATIENTS AND METHODS: We retrospectively analyzed a study of children <24 months old presenting to the emergency department with bronchiolitis. Demographic, clinical information, nasal wash (NW), and serum specimens were obtained. NW samples were analyzed for respiratory viruses, caspase 3/7 activity, and a panel of cytokines and chemokines. Total LDH activity was tested in NW samples and sera. RESULTS: Of 101 enrolled children (median age: 5.6 months), 98 had NW specimens available. A viral etiology was found for 82 patients (83.6%), with respiratory syncytial virus (RSV) (66%) and rhinovirus (19%) being the most common viruses detected. Concentrations of LDH in NW specimens were independent from those in sera and were higher in children with RSV infection or with dual infection. Significant correlations were found between NW LDH and NW cytokines/chemokines. Similarly, NW LDH correlated with NW-caspase 3/7 activity (r = 0.75; P < .001). In a multivariate analysis, NW LDH concentration in the upper quartile was significantly associated with a reduced risk of hospitalization (odds ratio: 0.19 [95% confidence interval: 0.05-0.68]; P = .011). CONCLUSIONS: NW LDH levels in young children with bronchiolitis varied according to viral etiology and disease severity. Values in the upper quartile were associated with approximately 80% risk reduction in hospitalization, likely reflecting a robust antiviral response. NW LDH may be a useful biomarker to assist the clinician in the decision to hospitalize a child with bronchiolitis.
OBJECTIVE: Because the decision to hospitalize an infant with bronchiolitis is often supported by subjective criteria and objective indicators of bronchiolitis severity are lacking, we tested the hypothesis that lactate dehydrogenase (LDH), which is released from injured cells, is a useful biochemical indicator of bronchiolitis severity. PATIENTS AND METHODS: We retrospectively analyzed a study of children <24 months old presenting to the emergency department with bronchiolitis. Demographic, clinical information, nasal wash (NW), and serum specimens were obtained. NW samples were analyzed for respiratory viruses, caspase 3/7 activity, and a panel of cytokines and chemokines. Total LDH activity was tested in NW samples and sera. RESULTS: Of 101 enrolled children (median age: 5.6 months), 98 had NW specimens available. A viral etiology was found for 82 patients (83.6%), with respiratory syncytial virus (RSV) (66%) and rhinovirus (19%) being the most common viruses detected. Concentrations of LDH in NW specimens were independent from those in sera and were higher in children with RSV infection or with dual infection. Significant correlations were found between NW LDH and NW cytokines/chemokines. Similarly, NW LDH correlated with NW-caspase 3/7 activity (r = 0.75; P < .001). In a multivariate analysis, NW LDH concentration in the upper quartile was significantly associated with a reduced risk of hospitalization (odds ratio: 0.19 [95% confidence interval: 0.05-0.68]; P = .011). CONCLUSIONS: NW LDH levels in young children with bronchiolitis varied according to viral etiology and disease severity. Values in the upper quartile were associated with approximately 80% risk reduction in hospitalization, likely reflecting a robust antiviral response. NW LDH may be a useful biomarker to assist the clinician in the decision to hospitalize a child with bronchiolitis.
Authors: Jeroen Maertzdorf; Chiaoyin K Wang; Jennifer B Brown; Joseph D Quinto; Marla Chu; Miranda de Graaf; Bernadette G van den Hoogen; Richard Spaete; Albert D M E Osterhaus; Ron A M Fouchier Journal: J Clin Microbiol Date: 2004-03 Impact factor: 5.948
Authors: Job B van Woensel; René Lutter; Maarten H Biezeveld; Tamara Dekker; Monique Nijhuis; Wim M van Aalderen; Taco W Kuijpers Journal: Pediatr Infect Dis J Date: 2003-08 Impact factor: 2.129
Authors: Federico R Laham; Victor Israele; Javier M Casellas; Alejandro M Garcia; Carlos M Lac Prugent; Scott J Hoffman; Debra Hauer; Bhagvanji Thumar; Maria Ivonne Name; Andres Pascual; Natalia Taratutto; Maria T Ishida; Marcela Balduzzi; Miguelina Maccarone; Susana Jackli; Roberto Passarino; Raul A Gaivironsky; Ruth A Karron; Norberto R Polack; Fernando P Polack Journal: J Infect Dis Date: 2004-05-06 Impact factor: 5.226
Authors: B G van den Hoogen; J C de Jong; J Groen; T Kuiken; R de Groot; R A Fouchier; A D Osterhaus Journal: Nat Med Date: 2001-06 Impact factor: 53.440
Authors: Lia van der Hoek; Krzysztof Pyrc; Maarten F Jebbink; Wilma Vermeulen-Oost; Ron J M Berkhout; Katja C Wolthers; Pauline M E Wertheim-van Dillen; Jos Kaandorp; Joke Spaargaren; Ben Berkhout Journal: Nat Med Date: 2004-03-21 Impact factor: 53.440
Authors: Jonathan M Mansbach; Pedro A Piedra; Federico R Laham; Alexander J McAdam; Sunday Clark; Ashley F Sullivan; Carlos A Camargo Journal: Pediatr Infect Dis J Date: 2012-07 Impact factor: 2.129
Authors: Cesar Mella; M Carmen Suarez-Arrabal; Santiago Lopez; Julie Stephens; Soledad Fernandez; Mark W Hall; Octavio Ramilo; Asuncion Mejias Journal: J Infect Dis Date: 2012-11-29 Impact factor: 5.226
Authors: Asad I Mian; Federico R Laham; Andrea T Cruz; Harsha Garg; Charles G Macias; A Chantal Caviness; Pedro A Piedra Journal: Open Respir Med J Date: 2012-11-14
Authors: Robert B Couch; Robert L Atmar; Luis M Franco; John M Quarles; Diane Niño; Janet M Wells; Nancy Arden; Sheree Cheung; John W Belmont Journal: Clin Infect Dis Date: 2011-11-10 Impact factor: 9.079
Authors: Reena Mehta; Margaret Scheffler; Lorena Tapia; Letisha Aideyan; Kirtida D Patel; Alan M Jewell; Vasanthi Avadhanula; Minghua Mei; Roberto P Garofalo; Pedro A Piedra Journal: Influenza Other Respir Viruses Date: 2014-08-12 Impact factor: 4.380